Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

- Bernhard, Jürg, Luo, Weixiu, Pavesi, Lorenzo, Parmar, Vani, Regan, Meredith M., Pagani, Olivia, Fleming, Gini F., Francis, Prudence A., Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Ribi, Karin, Walley, Barbara A., Colleoni, Marco, Burstein, Harold J., Tondini, Carlo, Pinotti, Graziella, Spazzapan, Simon, Ruhstaller, Thomas, Puglisi, Fabio

Tailoring adjuvant endocrine therapy for premenopausal breast cancer

- Francis, Prudence A., Pagani, Olivia, Bennefoi, Herve R., Bellet, Meritxell, Martino, Silvana, Geyer, Jr., Charles E., Goetz, Matthew P., Stearns, Vered, Pinotti, Graziella, Puglisi, Fabio, Spazzapan, Simon, Climent, Miguel A., Fleming, Gini F., Pavesi, Lorenzo, Ruhstaller, Thomas, Davidson, Nancy E., Coleman, Robert, Debled, Marc, Buchholz, Stefan, Ingle, James N., Winer, Eric P., Maibach, Rudolf, Rabaglio-Porretti, Manuela, Walley, Barbara A., Ruepp, Barbara, Di Leo, Angelo, Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Regan, Meredith M., Colleoni, Marco, Lang, Istvan, Gomez, Henry L., Tondini, Carlo, Ciruelos, Eva, Burstein, Harold J.

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

- Phillips, Kelly-Anne, Regan, Meredith, Abdi, Ehtesham, Domchek, Susan, Feng, Yang, Price, Karen, Coates, Alan, Gelber, Richard, Maruff, Paul, Boyle, Frances, Forbes, John F., Ahles, Tim, Ribi, Karin, Fleming, Gini, Bernhard, Jürg, Francis, Prudence A., Puglisi, Fabio, Bellet, Meritxell, Spazzapan, Simon, Karlsson, Per, Budman, Daniel, Zaman, Khalil